Yu Teranishi

Tokyo, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 63 publications

Chromosome-scale genome remodeling in tumor evolution: Copy number alterations and structural variants as two sides of the same coin.

Chromosome-scale genome remodeling in tumor evolution: Copy number alterations and structural variants as two sides of the same coin.

Journal: Critical reviews in oncology/hematology

Published: April 24, 2026

TANC1::HTRA1 and KPNA4::WWTR1 fusions in non-vestibular intracranial schwannomas.

TANC1::HTRA1 and KPNA4::WWTR1 fusions in non-vestibular intracranial schwannomas.

Journal: Acta neuropathologica

Published: February 13, 2026

Correction: Molecular insights into prognostic model for meningiomas treated with stereotactic radiosurgery: negative impacts of 1q gain on tumor control and survival.

Correction: Molecular insights into prognostic model for meningiomas treated with stereotactic radiosurgery: negative impacts of 1q gain on tumor control and survival.

Journal: Acta neuropathologica communications

Published: December 16, 2025

Optic nerve sheath meningioma exhibits neural niche-associated transcriptomic features and rare copy number variation-linked evolution.

Optic nerve sheath meningioma exhibits neural niche-associated transcriptomic features and rare copy number variation-linked evolution.

Journal: Brain pathology (Zurich, Switzerland)

Published: November 18, 2025

Molecular Pathogenesis, Genetic Profiles, and Therapeutic Strategies for NF2-Related Schwannomatosis

Molecular Pathogenesis, Genetic Profiles, and Therapeutic Strategies for NF2-Related Schwannomatosis

Journal: No shinkei geka. Neurological surgery

Published: August 20, 2025

Molecular insights into prognostic model for meningiomas treated with stereotactic radiosurgery: negative impacts of 1q gain on tumor control and survival.

Molecular insights into prognostic model for meningiomas treated with stereotactic radiosurgery: negative impacts of 1q gain on tumor control and survival.

Journal: Acta neuropathologica communications

Published: August 17, 2025

Sequential omics analysis reveals molecular signatures of malignant transformation in recurrent meningiomas.

Sequential omics analysis reveals molecular signatures of malignant transformation in recurrent meningiomas.

Journal: Acta neuropathologica communications

Published: June 12, 2025

Two molecular subtypes of skull base meningiomas with extracranial extension.

Two molecular subtypes of skull base meningiomas with extracranial extension.

Journal: Acta neuropathologica communications

Published: May 22, 2025

RNF213 c.14429G > A (p.Arg4810Lys) is associated with non-arteritic retinal artery occlusion.

RNF213 c.14429G > A (p.Arg4810Lys) is associated with non-arteritic retinal artery occlusion.

Journal: Scientific reports

Published: May 06, 2025

Merlin immunohistochemistry is a reliable surrogate marker for NF2 gene alterations in meningioma.

Merlin immunohistochemistry is a reliable surrogate marker for NF2 gene alterations in meningioma.

Journal: Histopathology

Published: May 02, 2025

Integrated molecular and detailed anatomical profiling identifies a prognostically adverse subtype of posterior fossa meningiomas: high-risk copy number alterations are associated with midline predilection and predict poor prognosis.

Integrated molecular and detailed anatomical profiling identifies a prognostically adverse subtype of posterior fossa meningiomas: high-risk copy number alterations are associated with midline predilection and predict poor prognosis.

Journal: Acta neuropathologica communications

Published: April 26, 2025

Clinical Significance of Somatic PIK3CA and MAP3K3 Mutations in Cerebral and Spinal Cavernous Malformations.

Clinical Significance of Somatic PIK3CA and MAP3K3 Mutations in Cerebral and Spinal Cavernous Malformations.

Journal: Translational stroke research

Published: April 08, 2025

Showing 1-12 of 63

Last Updated: 09/26/2026